Cargando…

Suppression of Metastatic Ovarian Cancer Cells by Bepridil, a Calcium Channel Blocker

Although surgery followed by platinum-based therapy is effective as a standard treatment in the early stages of ovarian cancer, the majority of cases are diagnosed at advanced stages, leading to poor prognosis. Thus, the identification of novel therapeutic drugs is needed. In this study, we assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Songzi, Kim, Dokyeong, Park, Minyoung, Yin, Jing Hu, Park, Junseong, Chung, Yeun-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381520/ https://www.ncbi.nlm.nih.gov/pubmed/37511982 http://dx.doi.org/10.3390/life13071607

Ejemplares similares

Non-Selective Calcium Channel Blocker Bepridil Decreases Secondary Pathology in Mice after Photothrombotic Cortical Lesion
por: Lipsanen, Anu, et al.
Publicado: (2013)

Effects of bepridil on early cardiac development of zebrafish
por: Wei, Ya-Lan, et al.
Publicado: (2022)

Bepridil, a class IV antiarrhythmic agent, can block the TREK-1 potassium channel
por: Wang, Ying, et al.
Publicado: (2021)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats
por: Sarajärvi, Timo, et al.
Publicado: (2012)

Bepridil is potent against SARS-CoV-2 In Vitro
por: Vatansever, Erol C., et al.
Publicado: (2020)

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Responsiveness to bepridil predicts atrial substrate in patients with persistent atrial fibrillation
por: Yakabe, Daisuke, et al.
Publicado: (2021)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Comparison of electrophysiological effects of calcium channel blockers on cardiac repolarization
por: Lee, Hyang-Ae, et al.
Publicado: (2016)

Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
por: Shimano, Ken, et al.
Publicado: (2021)

Bepridil monotherapy failed to prevent coronary vasospasm in a Brugada syndrome patient
por: Kazatani, Takuro, et al.
Publicado: (2022)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers
por: Park, Hwan-Woo, et al.
Publicado: (2014)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023)

Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
por: Mendez, Sean R., et al.
Publicado: (2021)

3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP
por: Tikunova, Svetlana B., et al.
Publicado: (2019)

Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers
por: Xu, Guanlan, et al.
Publicado: (2012)

Reduction of blood pressure by store‐operated calcium channel blockers
por: Xu, Yan‐Jun, et al.
Publicado: (2015)

Effects of Calcium Ion, Calpains, and Calcium Channel Blockers on Retinitis Pigmentosa
por: Nakazawa, Mitsuru
Publicado: (2011)

Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008)

Prognostic factors of acute calcium-channel blocker poisonings
por: Karyo, S, et al.
Publicado: (2008)

Bio-Inspired Voltage-Dependent Calcium Channel Blockers
por: Yang, Tingting, et al.
Publicado: (2013)

Calcium channel blocker in patients with chronic kidney disease
por: Ohno, Shoko, et al.
Publicado: (2021)

Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Abdullah, Hannan Safiyyah Tan Sian Hui, et al.
Publicado: (2021)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

Calcium Channel Blocker Toxicity: A Practical Approach
por: Alshaya, Omar A, et al.
Publicado: (2022)

Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers
por: Rajagopal, Sudarshan, et al.
Publicado: (2023)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Wang, Ji-Guang
Publicado: (2009)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vv1rn6kg8bkbn7u9dk4slkugmm